Luminex pneumococcal assay identifies 14 serotypes simultaneously

The Luminex Pneumococcal Assay was developed using the benefits of Luminex's multiplexing xMAP platform.

The assay has been designed to multiplex the fourteen most commonly requested serotypes in a single reaction vessel and can be used on the existing installed base of Luminex instrumentation.

Click here to find out more about Luminex xMap® Technology


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Luminex Corporation View archived contact details

Posted on November 6, 2006